The spliceosome component Usp39 controls B cell development by regulating immunoglobulin gene rearrangement
The spliceosome is a large ribonucleoprotein complex responsible for pre-mRNA splicing and genome stability maintenance. Disruption of the spliceosome activity may lead to developmental disorders and tumorigenesis. However, the physiological role that the spliceosome plays in B cell development and...
Saved in:
Published in | Cell reports (Cambridge) Vol. 38; no. 6; p. 110338 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
08.02.2022
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The spliceosome is a large ribonucleoprotein complex responsible for pre-mRNA splicing and genome stability maintenance. Disruption of the spliceosome activity may lead to developmental disorders and tumorigenesis. However, the physiological role that the spliceosome plays in B cell development and function is still poorly defined. Here, we demonstrate that ubiquitin-specific peptidase 39 (Usp39), a spliceosome component of the U4/U6.U5 tri-snRNP complex, is essential for B cell development. Ablation of Usp39 in B cell lineage blocks pre-pro-B to pro-B cell transition in the bone marrow, leading to a profound reduction of mature B cells in the periphery. We show that Usp39 specifically regulates immunoglobulin gene rearrangement in a spliceosome-dependent manner, which involves modulating chromatin interactions at the Igh locus. Moreover, our results indicate that Usp39 deletion reduces the pre-malignant B cells in Eμ-Myc transgenic mice and significantly improves their survival.
[Display omitted]
•Usp39 is essential for early B cell development in the bone marrow•Usp39 regulates immunoglobulin gene rearrangement in a spliceosome-dependent manner•Usp39 modulates chromatin interaction at the Igh locus•Deletion of Usp39 mitigates B cell lymphomagenesis in Eμ-Myc transgenic mice
Ruan et al. report that the spliceosome component Usp39 is essential for B cell development by regulating immunoglobulin gene rearrangement. These results suggest that Usp39 could be a potential therapeutic target for B cell lymphomas |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2022.110338 |